Atezolizumab plus bevacizumab for patients with Child-Pugh-B in hepatocellular carcinoma

被引：2
作者：
Itoh, Shinji [1 ]
Ikeda, Masafumi [2 ]
机构：
[1] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan
[2] Natl Canc Ctr Hosp East, Dept Hepatobiliary & Pancreat Oncol, Kashiwa, Japan
来源：
HEPATOBILIARY SURGERY AND NUTRITION | 2022年
关键词：
D O I：
10.21037/hbsn-22-432
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Atezolizumab and Bevacizumab in Hepatocellular Carcinoma
    Bomze, David
    Meirson, Tomer
    Azoulay, Daniel
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (07) : 693 - 694
  • [32] Efficacy and safety of atezolizumab plus bevacizumab in patients with portal hypertension for unresectable hepatocellular carcinoma
    Kinami, Takahiro
    Uchikawa, Shinsuke
    Kawaoka, Tomokazu
    Yamasaki, Shintaro
    Kosaka, Masanari
    Johira, Yusuke
    Yano, Shigeki
    Amioka, Kei
    Naruto, Kensuke
    Yamaoka, Kenji
    Fujii, Yasutoshi
    Fujino, Hatsue
    Nakahara, Takashi
    Ono, Atsushi
    Murakami, Eisuke
    Okamoto, Wataru
    Yamauchi, Masami
    Miki, Daiki
    Tsuge, Masataka
    Oka, Shiro
    [J]. CANCER MEDICINE, 2024, 13 (05):
  • [33] Combination of Radiotherapy and Atezolizumab plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma: A Pilot Study
    Hur, Y. J.
    Kim, J.
    Seong, J.
    Lee, C. K.
    Kim, B. K.
    Kim, D. Y.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E304 - E305
  • [34] Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma
    Mathew Vithayathil
    Antonio D’Alessio
    Claudia Angela Maria Fulgenzi
    Naoshi Nishida
    Martin Schönlein
    Johann von Felden
    Kornelius Schulze
    Henning Wege
    Anwaar Saeed
    Brooke Wietharn
    Hannah Hildebrand
    Linda Wu
    Celina Ang
    Thomas U. Marron
    Arndt Weinmann
    Peter R. Galle
    Dominik Bettinger
    Bertram Bengsch
    Arndt Vogel
    Lorenz Balcar
    Bernhard Scheiner
    Pei-Chang Lee
    Yi-Hsiang Huang
    Suneetha Amara
    Mahvish Muzaffar
    Abdul Rafeh Naqash
    Antonella Cammarota
    Valentina Zanuso
    Tiziana Pressiani
    Matthias Pinter
    Alessio Cortellini
    Masatoshi Kudo
    Lorenza Rimassa
    David J. Pinato
    Rohini Sharma
    [J]. Hepatology International, 2023, 17 : 904 - 914
  • [35] The prediction of early progressive disease in patients with hepatocellular carcinoma receiving atezolizumab plus bevacizumab
    Takeuchi, Yasuto
    Nouso, Kazuhiro
    Fujioka, Shin-ichi
    Kariyama, Kazuya
    Kobashi, Haruhiko
    Uematsu, Shuji
    Moriya, Akio
    Hagihara, Hiroaki
    Takabatake, Hiroyuki
    Nakamura, Shinichiro
    Yabushita, Kazuhisa
    Kikuchi, Tatsuya
    Oyama, Atsushi
    Adachi, Takuya
    Wada, Nozomu
    Onishi, Hideki
    Shiraha, Hidenori
    Takaki, Akinobu
    [J]. CANCER MEDICINE, 2023, 12 (17): : 17559 - 17568
  • [36] Feasibility of Gemcitabine plus Oxaliplatin in Advanced Hepatocellular Carcinoma Patients with Child-Pugh B Cirrhosis
    Dhooge, Marion
    Coriat, Romain
    Mir, Olivier
    Perkins, Geraldine
    Brezault, Catherine
    Boudou-Rouquette, Pascaline
    Goldwasser, Francois
    Chaussade, Stanislas
    [J]. ONCOLOGY, 2013, 84 (01) : 32 - 38
  • [37] Hepatic Events and Viral Kinetics in Hepatocellular Carcinoma Patients Treated With Atezolizumab Plus Bevacizumab
    Hsu, Chiun
    Ducreux, Michel
    Zhu, Andrew X.
    Qin, Shukui
    Ikeda, Masafumi
    Kim, Tae-You
    Galle, Peter R.
    Finn, Richard S.
    Chen, Ethan
    Ma, Ning
    Hu, Youyou
    Li, Lindong
    Cheng, Ann-Lii
    [J]. LIVER CANCER, 2023, 12 (01) : 44 - 56
  • [38] Analysis of varix bleeding after Atezolizumab plus Bevacizumab for advanced hepatocellular carcinoma patients
    Lee, Ahlim
    Kim, Hee Yeon
    [J]. JOURNAL OF HEPATOLOGY, 2024, 80 : S458 - S458
  • [39] Atezolizumab Plus Bevacizumab in Patients with Advanced and Progressing Hepatocellular Carcinoma: Retrospective Multicenter Experience
    Sinner, Friedrich
    Pinter, Matthias
    Scheiner, Bernhard
    Ettrich, Thomas Jens
    Sturm, Niklas
    Gonzalez-Carmona, Maria A.
    Waidmann, Oliver
    Finkelmeier, Fabian
    Himmelsbach, Vera
    De Toni, Enrico N.
    Ben Khaled, Najib
    Mohr, Raphael
    Fruendt, Thorben Wilhelm
    Kuetting, Fabian
    van Boemmel, Florian
    Lieb, Sabine
    Krug, Sebastian
    Bettinger, Dominik
    Schultheiss, Michael
    Jochheim, Leonie S.
    Best, Jan
    Mueller, Christian
    Keitel, Verena
    Venerito, Marino
    [J]. CANCERS, 2022, 14 (23)
  • [40] Analysis of the tumor microenvironment in ineffective patients of atezolizumab plus bevacizumab for advanced hepatocellular carcinoma
    Kobayashi, Kazufumi
    Ogasawara, Sadahisa
    Ishino, Takamasa
    Unozawa, Hidemi
    Nakagawa, Miyuki
    Fujiwara, Kisako
    Sakuma, Takafumi
    Fujita, Naoto
    Kanzaki, Hiroaki
    Koroki, Keisuke
    Nakamura, Masato
    Kiyono, Soichiro
    Kanogawa, Naoya
    Kondo, Takayuki
    Saito, Tomoko
    Nakagawa, Ryo
    Nakamoto, Shingo
    Muroyama, Ryosuke
    Chiba, Tetsuhiro
    Kato, Naoya
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
12345